Page last updated: 2024-10-17

3,4-dihydroxyphenylacetic acid and Autonomic Failure, Pure

3,4-dihydroxyphenylacetic acid has been researched along with Autonomic Failure, Pure in 2 studies

3,4-Dihydroxyphenylacetic Acid: A deaminated metabolite of LEVODOPA.
(3,4-dihydroxyphenyl)acetic acid : A dihydroxyphenylacetic acid having the two hydroxy substituents located at the 3- and 4-positions. It is a metabolite of dopamine.
dihydroxyphenylacetic acid : A dihydroxy monocarboxylic acid consisting of phenylacetic acid having two phenolic hydroxy substituents.

Research Excerpts

ExcerptRelevanceReference
"The three synucleinopathies therefore have in common in vivo evidence of central noradrenergic deficiency but differ in the extents of central dopaminergic deficiency-prominent in PD and MSA, less apparent in PAF."1.62Differential abnormalities of cerebrospinal fluid dopaminergic versus noradrenergic indices in synucleinopathies. ( Goldstein, DS; Holmes, C; Lamotte, G; Lenka, A; Sharabi, Y; Sullivan, P, 2021)
"Parkinson's disease and pure autonomic failure involve differential dopaminergic versus noradrenergic lesions."1.38Cerebrospinal fluid biomarkers of central catecholamine deficiency in Parkinson's disease and other synucleinopathies. ( Goldstein, DS; Holmes, C; Sharabi, Y, 2012)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's1 (50.00)2.80

Authors

AuthorsStudies
Goldstein, DS2
Sullivan, P1
Holmes, C2
Lamotte, G1
Lenka, A1
Sharabi, Y2

Other Studies

2 other studies available for 3,4-dihydroxyphenylacetic acid and Autonomic Failure, Pure

ArticleYear
Differential abnormalities of cerebrospinal fluid dopaminergic versus noradrenergic indices in synucleinopathies.
    Journal of neurochemistry, 2021, Volume: 158, Issue:2

    Topics: 3,4-Dihydroxyphenylacetic Acid; Aged; Cohort Studies; Dopamine; Dopaminergic Neurons; Female; Homova

2021
Cerebrospinal fluid biomarkers of central catecholamine deficiency in Parkinson's disease and other synucleinopathies.
    Brain : a journal of neurology, 2012, Volume: 135, Issue:Pt 6

    Topics: 3,4-Dihydroxyphenylacetic Acid; Aged; Biomarkers; Catecholamines; Dopamine Agents; Female; Fluorodeo

2012